Goldman Sachs Resumes on Carter's at Neutral on Valuation

Loading...
Loading...
In a report published by Goldman Sachs, analyst Taposh Bari resumed coverage on Carter's
CRI
with a Neutral rating and a $61 price target. Goldman Sachs reported that, "On its 4Q12 earnings call, CRI management guided for another year of doubledigit EPS growth in 2013. Guidance, which includes dilution from the Japanese licensee acquisition, calls for 15% EPS growth (19% excluding the dilution). While the guidance appears achievable, we believe management has set an ambitious plan for the year ahead with a number of initiatives on the table: distribution center transition, integration of the Japanese licensee, 13% square footage growth, and the consolidation of its headquarters. While confident in management's ability to execute this plan, we find it difficult to justify paying a premium multiple given a relatively elevated near-term risk profile.” Shares of Carter's closed at $57.41 on Thursday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorInitiationAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...